Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
This is an antibody preparation generated in rabbit by Dr. William North Professor of Physiology and Neurobiology of Dartmouth Medical School (now Geisel Medical School at Dartmouth) using arginine- vasopressin coupled to bovine thyroglobulin.
Specificity: Less than 0.1% cross-reactivity with oxytocin, in RIA
Tested Applications IHC-formaldehyde fixed tissues, Flow cytometry, , RIA, ELISA
Properties
Form: Liquid
Storage Instructions: Shipped at 4 o C. Store at 4 o C short term (1-2 weeks). Upon delivery aliquot and store at -20 o C or -80 o C. Avoid freeze/Thaw cycling.
Storage buffer: Preservative none -Stable if stored as 1:100 dilutions in PBS containing 1.25 mg/ml of BSA at -20 o C.
Constituents: Whole serum
Purity: Whole Antiserum
Clonality: Polyclonal
Isotype: IgG, Behaves chromatographically like mouse IgG2B
Research Areas: Neuroscience, Endocrinology, Neuropeptides, Hormones, Neuroendocrinology, OBGYN, Cancer
----------------------------------------------------------------------------------
Woomera Therapeutics Inc. guarantees use of FZE in each of the tested applications:
The application information recommends certain starting dilutions; however, optimal dilutions/concentrations should be determined by the end user.
Application
IHC: Use at an assay dependent concentration
RIA: 1/30,000-99,000. Sensitivity to 0.4 pg/ml; 50% displacement ~5 pg, range 0.4-32 pg; <0.1% OT cross-reaction.
ELISA: 1/30,000-50,000
Flow Cytometry: 1/1000-5000
Western: 1/1000-5000
References
North, W.G. Neuropeptide production by small-cell carcinoma: Vasopressin and oxytocin as plasma markers of disease. J. Clin. Endocrin. Metab. 73:1316-1320, 1991.
Cheng, S.W.T., and North, W.G. Absence of negative feedback by oxytocin on release from magnocellular neurones in conscious rats. Can. J. Physiol. Pharmacol. 70(1):100-105, 1992.
Piqueux, C., Hagelstein M.T., Keegan, B., Legros, V., and North, W.G. Vasopressin and Oxytocin mitogen transduction pathway in small cell lung cancer cells. Endocr.-Relat. Cancer, 4:871- 875, 2004.
Product Code FZE
Copyright © 2025 Woomera Therapeutics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.